Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C17H17Cl2N.ClH |
Molecular Weight | 342.691 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 2 / 2 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
Cl.CN[C@@H]1CC[C@H](C2=CC(Cl)=C(Cl)C=C2)C3=C1C=CC=C3
InChI
InChIKey=BLFQGGGGFNSJKA-JSUROZADSA-N
InChI=1S/C17H17Cl2N.ClH/c1-20-17-9-7-12(13-4-2-3-5-14(13)17)11-6-8-15(18)16(19)10-11;/h2-6,8,10,12,17,20H,7,9H2,1H3;1H/t12-,17-;/m1./s1
cis-(-)-Sertraline (aka 1R,4R-sertraline) is the therapeutically inactive enantiomer of Sertraline. Sertraline has four stereoisomers: (1R,4R), (1S,4S), (1R,4S), and (1S,4R), of which the (1S,4S) isomer is the active therapeutic compound. Sertraline is sold under the brand name Zoloft (and others) as an anti-depressant acting as a selective serotonin reuptake inhibitor. The bio-activity of sertraline is restricted to (1S,4S), and (1R,4R), where (1S,4S) is most potent.
Originator
Sources: https://www.google.com/patents/EP0030081B1
Curator's Comment: # Pfizer Inc.
Approval Year
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
13408688
Created by
admin on Sat Dec 16 07:58:28 GMT 2023 , Edited by admin on Sat Dec 16 07:58:28 GMT 2023
|
PRIMARY | |||
|
79645-15-1
Created by
admin on Sat Dec 16 07:58:28 GMT 2023 , Edited by admin on Sat Dec 16 07:58:28 GMT 2023
|
PRIMARY | |||
|
H0905KBO3H
Created by
admin on Sat Dec 16 07:58:28 GMT 2023 , Edited by admin on Sat Dec 16 07:58:28 GMT 2023
|
PRIMARY |
SUBSTANCE RECORD